ArticleFrontiers in cell and developmental biology2026
Prior copper intrauterine device use and reproductive outcomes after embryo transfer in IVF/ICSI cycles: a propensity score-matched cohort study.
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The copper intrauterine device (Cu-IUD) is a widely used long-term contraceptive method. However, whether prior Cu-IUD use, including long-term exposure, affects reproductive and neonatal outcomes after assisted reproductive technology (ART) remains unclear. This study evaluated the association between prior Cu-IUD use and outcomes after embryo transfer in IVF/ICSI cycles. Methods: This retrospective cohort study included 62,422 embryo transfer cycles (27,692 fresh and 34,730 frozen-thawed embryo transfer cycles) performed between September 2008 and December 2023. Of these, 3,151 cycles involved women with a history of Cu-IUD use and 59,271 cycles involved women without any IUD history. Propensity score matching (1:2) was performed separately for fresh and frozen embryo transfer cohorts. The primary outcome was live birth rate per embryo transfer. Secondary outcomes included biochemical pregnancy, clinical pregnancy, miscarriage, multiple birth, and low birth weight. Results: After matching, baseline characteristics were well balanced between groups. In fresh embryo transfer cycles, live birth rates were comparable between women with and without prior Cu-IUD use (28.0% vs. 27.7%; adjusted RR 1.01, 95% CI 0.91-1.11). Similar results were observed in frozen embryo transfer cycles (23.1% vs. 23.6%; adjusted RR 0.97, 95% CI 0.87-1.07). No significant differences were observed in biochemical pregnancy, clinical pregnancy, miscarriage, multiple birth, or low birth weight between groups in either fresh or frozen embryo transfer cycles. Stratified analyses showed no clinically relevant effect modification by age, AMH, or BMI. Conclusion: Within this study, prior Cu-IUD use, including long-term use, was not found to be associated with adverse reproductive or neonatal outcomes after embryo transfer in IVF/ICSI cycles. These results do not provide evidence to support additional ART interventions based solely on prior Cu-IUD history.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.